主旨：ichitakajoe 违反板规1-2-2，删文水桶一周。
deann 违反板规4-5-1，删文水桶一周。
ANDORLESS 违反板规4-2-1，删文水桶一周。
说明：经板主巡视板面，ichitakajoe 新闻没有节录完整，违反板规1-2-2，删文水桶一周
deann 文章内容最后两行明显引战高雄，违反板规4-5-1，删文水桶一周。
ANDORLESS 文章闲聊，违反板规4-2-1，删文水桶一周。
具体事证：
#1UcECBGx
作者 ichitakajoe (joe) 看板 Stock
标题 [新闻] 瑞德西韦早期报告
时间 Fri Apr 17 06:58:17 2020
───────────────────────────────────────
1.原文连结：
https://reurl.cc/V6829R
2.原文内容：
A Chicago hospital treating severe Covid-19 patients with Gilead Sciences' ant
iviral medicine remdesivir in a closely watched clinical trial is seeing rapid
recoveries in fever and respiratory symptoms, with nearly all patients discha
rged in less than a week, STAT has learned.
一个芝加哥的医院收疗严重Covid病患的试验，使用药物后发烧及呼吸道症状改善，几乎
所有病人一周内出院。
The University of Chicago Medicine recruited 125 people with Covid-19 into Gil
ead's two Phase 3 clinical trials. Of those people, 113 had severe disease. Al
l the patients have been treated with daily infusions of remdesivir.
"The best news is that most of our patients have already been discharged, whic
h is great. We've only had two patients perish," said Kathleen Mullane, the Un
iversity of Chicago infectious disease specialist overseeing the remdesivir st
udies for the hospital.
125位病人中，113位为严重型患者。两位死亡。
3.心得/评论：
原文其他内容是一些描述，例如此试验非双盲设计，无对照组。
四月底之前应该会有NEJM等级报告出来，到时候就可以知道细节。
不过就像教主说的，等知道细节都不知道喷到哪里去了，美国防疫股盘后都大涨。